电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

HBsAb ELISA 试剂盒

This Hepatitis B Virus (HBV) HBsAb ELISA Kit is a Colorimetric ELISA Kit designed to quantify Hepatitis B Virus (HBV) HBsAb.
产品编号 ABIN997016
发货至: 中国

Quick Overview for HBsAb ELISA 试剂盒 (ABIN997016)

抗原

See all HBsAb products
HBsAb (Anti-Hepatitis B Virus Surface Antibody (HBsAb))

适用

  • 4
  • 3
  • 3
  • 1
  • 1
  • 1
Hepatitis B Virus (HBV)

检测方法

Colorimetric

实验类型

Sandwich ELISA

应用范围

ELISA

样品类型

Serum
  • 原理

    HBsAb ELISA Test is an enzyme linked immunosorbent assay (ELISA) for in vitro qualitative detection of antibodies to hepatitis B virus surface antigen (anti-HBs) in human serum or plasma.

    Analytical Method

    Qualitative

    特异性

    99.70%

    灵敏度

    100%
  • 样本量

    50 μL

    实验时间

    1 - 2 h

    板类型

    Pre-coated

    限制

    仅限研究用
  • 储存条件

    4 °C

    有效期

    12-18 months
  • 抗原 See all HBsAb products

    HBsAb (Anti-Hepatitis B Virus Surface Antibody (HBsAb))

    别名

    HbsAb

    物质类

    Antibody, Antibody

    背景

    Hepatitis B virus (HBV) is an enveloped, double-stranded DNA virus belonging to the Hepadnaviridae family and is recognized as the major cause of blood transmitted hepatitis together with hepatitis C virus (HCV). Infection with HBV induces a spectrum of clinical manifestations ranging from mild, inapparent disease to fulminant hepatitis, severe chronic liver disease, which in some cases can lead to cirrhosis and carcinoma of the liver. Classification of a hepatitis B infection requires the identification of several serological markers expressed during three phases (incubation, acute and convalescent) of the infection. Now several diagnostic tests are used for screening, clinical diagnosis and management of the disease. Hepatitis B surface antigen (HBsAg), which appears shortly after infection is an important protein of the envelope structure of the virus.
    HBsAg is a key serological marker for detection and diagnosis of HBV and is detectable in blood during the acute phase of the disease. Clearance after treatment shows recovery while presence for more than half year after infection indicates possible progression to long chronic carrier stage. During the acute phase of the infection, strong immunological response develops and increasing titers of HBsAg neutralizing antibodies (anti-HBs) are marker for recovery. The serological detection of anti-HBs has become important method for the follow up of patients infected by HBV, prospective prevalence studies, and the monitoring of recipients upon vaccination with synthetic and natural HBsAg based vaccines.
You are here:
Chat with us!